FDG-PET/CT as a predictor of pathological complete response (pCR) in breast cancer (BC) patients (pts) treated with neoadjuvant chemotherapy (NAC): a single center retrospective study

被引：0
|
作者：
Inno, A. [1 ]
Lunardi, G. [2 ]
Turazza, M. [2 ]
Pasetto, S. [2 ]
Severi, F. [2 ]
Gorgoni, G. [2 ]
Bogina, G. [2 ]
Bortesi, L. [2 ]
Russo, A. [2 ]
Alongi, F. [2 ]
Fiorentino, A. [2 ]
Duranti, S. [2 ]
Massocco, A. [2 ]
Marchetti, F. [2 ]
Valerio, M. [2 ]
Salgarello, M. [2 ]
Gori, S. [2 ]
机构：
[1] Osped Sacro Cuore Don Calabria, Negrar, Italy
[2] Osped Sacro Cuore Don Calabria, Negrar Verona, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A20
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
    Alina Berriolo-Riedinger
    Claude Touzery
    Jean-Marc Riedinger
    Michel Toubeau
    Bruno Coudert
    Laurent Arnould
    Christophe Boichot
    Alexandre Cochet
    Pierre Fumoleau
    François Brunotte
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1915 - 1924
  • [2] [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
    Berriolo-Riedinger, Alina
    Touzery, Claude
    Riedinger, Jean-Marc
    Toubeau, Michel
    Coudert, Bruno
    Arnould, Laurent
    Boichot, Christophe
    Cochet, Alexandre
    Fumoleau, Pierre
    Brunotte, Francois
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (12) : 1915 - 1924
  • [3] FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results
    Buchbender, Christian
    Kuemmel, Sherko
    Hoffmann, Oliver
    Stahl, Alexander R.
    Kimmig, Rainer
    Otterbach, Friedrich
    Ladd, Susanne
    Koeninger, Angela
    Forsting, Michael
    Bockisch, Andreas
    Antoch, Gerald
    Heusner, Till A.
    [J]. ACTA RADIOLOGICA, 2012, 53 (06) : 628 - 636
  • [4] Impact of body mass index (BMI) on pathological complete response (pCR) and survival of breast cancer (BC) patients receiving neoadjuvant chemotherapy (NAC)
    Aguiar Bujanda, D.
    Ros Sanjuan, L.
    Perez Cabrera, D.
    Croissier Sanchez, L.
    Mori De Santiago, M.
    Hernandez Sosa, M.
    Vargas Prado, A. M.
    Galvan Ruiz, S.
    Antonilli Perez, C.
    Ten Benajes, R.
    Fox, B.
    Martinez Garcia-Cervantes, R.
    Rubio Romero, G.
    Hanselmann, R.
    Saura Grau, S.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S51 - S52
  • [5] Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)
    Fasching, P. A.
    Laible, M.
    Weber, K. E.
    Wirtz, R. M.
    Denkert, C.
    Schlombs, K.
    Schmatloch, S.
    Camara, O.
    Lueck, H. J.
    Huober, J.
    Karn, T.
    van Mackelenbergh, M. T.
    Marme, F.
    Mueller, V.
    Schem, C.
    Stickeler, E.
    Sahin, U.
    Loibl, S.
    Untch, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 53 - 53
  • [6] FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients
    Soubra, Ayman
    Gencturk, Mehmet
    Froelich, Jerry
    Balaji, Priya
    Gupta, Shilpa
    Jha, Gautam
    Konety, Badrinath R.
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 360 - 364
  • [7] Percentage of reduction in FDG-PET/CT imaging biomarkers as a predictor for pathological response in breast cancer patients
    Abd El-Gaid, Salwa
    Elahmadawy, Mai
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [8] PROGESTERONE RECEPTOR (PR) NEGATIVITY PREDICTS PATHOLOGICAL COMPLETE RESPONSE (PCR) AFTER NEOADJUVANT CHEMOTHERAPY (NACT) IN BREAST CANCER (BC) PATIENTS (PTS)
    Perez-Garcia, J. M.
    Saura, C.
    Munoz, E.
    Sanchez-Olle, G.
    Gomez, P.
    Di Cosimo, S.
    Sabadell, D.
    Cortes, J.
    Baselga, J.
    Bellet, M.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 53 - 54
  • [9] Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
    Andrade, W. P.
    Lima, E. N. P.
    Osorio, C. A. B. T.
    do Socorro Maciel, M.
    Baiocchi, G.
    Bitencourt, A. G. V.
    Fanelli, M. F.
    Damascena, A. S.
    Soares, F. A.
    [J]. EJSO, 2013, 39 (12): : 1358 - 1363
  • [10] The relationship among bowel FDG-PET uptake, pathological complete response, and eating habits in breast cancer patients undergoing neoadjuvant chemotherapy
    Tiberio, P.
    Antunovic, L.
    Gaudio, M.
    Vigano, A.
    Pastore, M.
    Miggiano, C.
    Jacobs, F.
    Benvenuti, C.
    Farina, E.
    Chiti, A.
    Santoro, A.
    De Sanctis, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 175 : S63 - S64
12345